Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G FORNI

Showing results (211-220 of 326) with videos related to

Pageof 33
Sort By:
Blood|September 1, 1985
Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell populationR Foa, M Giovarelli, C Jemma, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 27, 2018
Improving clinical prediction rules in acute kidney injury with the use of biomarkers of cell cycle arrest: a pilot studyLuke E Hodgson, Richard M Venn, Steve Short, et al.
Journal of the National Cancer Institute|July 16, 1997
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12F Cavallo, P Signorelli, M Giovarelli, et al.
Plos One|August 24, 2018
Correction: The ICE-AKI study: Impact analysis of a Clinical prediction rule and Electronic AKI alert in general medical patientsLuke E Hodgson, Paul J Roderick, Richard M Venn, et al.
European Journal of Immunology|February 1, 1994
Interleukin-2 prevention of apoptosis in human neutrophilsF Pericle, J H Liu, J I Diaz, et al.
British Journal of Cancer|November 3, 2005
Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomasG N Berta, B Mognetti, M Spadaro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
Expression and role in apoptosis of the alpha- and beta-chains of the IFN-gamma receptor on human Th1 and Th2 clonesF Novelli, M M D'Elios, P Bernabei, et al.
Cancer Gene Therapy|November 10, 2007
DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic miceC Curcio, A S Khan, A Amici, et al.
British Journal of Cancer|March 1, 1994
Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphaticallyG Cortesina, A De Stefani, E Galeazzi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 26, 1999
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular originE Di Carlo, M G Diodoro, K Boggio, et al.
Pageof 33

Showing results (211-220 of 326) with videos related to

Sort By:
Pageof 33
Blood|September 1, 1985
Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell populationR Foa, M Giovarelli, C Jemma, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 27, 2018
Improving clinical prediction rules in acute kidney injury with the use of biomarkers of cell cycle arrest: a pilot studyLuke E Hodgson, Richard M Venn, Steve Short, et al.
Journal of the National Cancer Institute|July 16, 1997
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12F Cavallo, P Signorelli, M Giovarelli, et al.
Plos One|August 24, 2018
Correction: The ICE-AKI study: Impact analysis of a Clinical prediction rule and Electronic AKI alert in general medical patientsLuke E Hodgson, Paul J Roderick, Richard M Venn, et al.
European Journal of Immunology|February 1, 1994
Interleukin-2 prevention of apoptosis in human neutrophilsF Pericle, J H Liu, J I Diaz, et al.
British Journal of Cancer|November 3, 2005
Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomasG N Berta, B Mognetti, M Spadaro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
Expression and role in apoptosis of the alpha- and beta-chains of the IFN-gamma receptor on human Th1 and Th2 clonesF Novelli, M M D'Elios, P Bernabei, et al.
Cancer Gene Therapy|November 10, 2007
DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic miceC Curcio, A S Khan, A Amici, et al.
British Journal of Cancer|March 1, 1994
Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphaticallyG Cortesina, A De Stefani, E Galeazzi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 26, 1999
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular originE Di Carlo, M G Diodoro, K Boggio, et al.
Pageof 33